Skip to main content
logo
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.050
-0.010 (-0.33%)
At close: Oct 30, 2026, 4:00 PM EDT
3.061
+0.011 (0.34%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Neuphoria Therapeutics Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
19.8714.2112.6112.123.13
Cash & Short-Term Investments
19.8714.2112.6112.123.13
Cash Growth
39.79%12.71%4.17%-47.66%8.23%
Other Receivables
0.810.010.130.434.67
Receivables
0.810.010.130.434.67
Prepaid Expenses
0.390.740.460.81.01
Restricted Cash
-0.08---
Total Current Assets
21.0715.0413.1913.3328.81
Property, Plant & Equipment
-0.110.220.330.46
Goodwill
3.58.648.698.698.87
Other Intangible Assets
4.144.85.476.136.78
Other Long-Term Assets
--0.080.080.08
Total Assets
28.7128.5927.6528.5645

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.391.152.241.441.07
Accrued Expenses
0.282.881.391.191.13
Short-Term Debt
0.030.030.03--
Current Portion of Leases
-0.120.120.110.11
Other Current Liabilities
0.050.040.04--
Total Current Liabilities
0.764.223.832.742.31
Long-Term Leases
--0.120.240.37
Pension & Post-Retirement Benefits
----0.01
Long-Term Deferred Tax Liabilities
0.360.50.961.11.24
Other Long-Term Liabilities
34.875.252.471.86
Total Liabilities
4.119.5910.166.555.79

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
000-149.99
Additional Paid-In Capital
218.46200.19198.48187.55-
Retained Earnings
-191.8-178.35-177.98-162.48-119.41
Comprehensive Income & Other
-2.06-2.85-3.01-3.068.63
Shareholders' Equity
24.61917.4922.0139.21
Total Liabilities & Equity
28.7128.5927.6528.5645

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
0.030.150.270.350.48
Net Cash (Debt)
19.8314.0612.3411.7522.65
Net Cash Growth
41.03%13.99%4.99%-48.12%9.32%
Net Cash Per Share
4.518.6614.820.010.02
Filing Date Shares Outstanding
5.412.363,1181,4691,353
Total Common Shares Outstanding
5.411.982,3851,4691,353
Working Capital
20.3110.829.3610.5926.49
Book Value Per Share
4.559.600.010.010.03
Tangible Book Value
16.965.563.337.1923.57
Tangible Book Value Per Share
3.132.810.000.000.02
SEC Filings: 10-K · 10-Q